Market Closed -
Other stock markets
|
After market 01:00:00 | |||
148.4 USD | +0.07% |
|
146.4 | -1.38% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | Other Pharmaceuticals | +0.07% | +0.07% | +358.59% | +358.59% | +358.59% | 352B | - | - | - |
- Stock Market
- Equities
- JNJ Stock
- 0R34 Stock
- Charts Johnson & Johnson
- Relative Strength Chart